These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8312587)

  • 1. The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model.
    Gibson DF; Johnson DA; Langan-Fahey SM; Lababidi MK; Wolberg WH; Jordan VC
    Breast Cancer Res Treat; 1993 Sep; 27(3):283-7. PubMed ID: 8312587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
    Robinson SP; Jordan VC
    Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of tamoxifen in laboratory animals.
    Jordan VC; Allen KE; Dix CJ
    Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
    Robinson SP; Mauel DA; Jordan VC
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1817-21. PubMed ID: 2975594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y; Schneider MR; Michna H
    J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
    Zaccheo T; Giudici D; Di Salle E
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):677-80. PubMed ID: 8476783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the hormone dependency of DMBA-induced rat mammary tumors with reference to the effect of tamoxifen.
    Inui K; Morimoto T; Komaki K; Sonoo H; Monden Y
    Jpn J Surg; 1988 May; 18(3):284-90. PubMed ID: 3136267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y; Takai Y; Sugamata N; Morishita Y
    Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.
    Pento JT; Magarian RA; King MM
    Cancer Lett; 1982; 15(3):261-9. PubMed ID: 6811128
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
    Ben-Hur H; Kossoy G; Zusman I
    Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen].
    Kamioki S
    Gan No Rinsho; 1986 Nov; 32(14):1809-18. PubMed ID: 3099030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
    Jordan VC; Dowse LJ
    J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
    Jordan VC; Allen KE
    Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
    [No Abstract]   [Full Text] [Related]  

  • 16. Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.
    Zhang X; Cook KL; Warri A; Cruz IM; Rosim M; Riskin J; Helferich W; Doerge D; Clarke R; Hilakivi-Clarke L
    Clin Cancer Res; 2017 Feb; 23(3):814-824. PubMed ID: 28148690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of styrylpyrone derivative (SPD) on 7,12-dimethylbenzanthracene-induced rat mammary tumors.
    Hawariah A; Stanslas J
    In Vivo; 1998; 12(4):403-10. PubMed ID: 9706492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidase activity in mammary tumors - effect of tamoxifen.
    Levy J; Liel Y; Feldman B; Aflallo L; Glick SM
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1023-6. PubMed ID: 6799299
    [No Abstract]   [Full Text] [Related]  

  • 20. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.